ArQule

$7.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (0.89%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ArQule and other stocks, options, ETFs, and crypto commission-free!

About ARQL

ArQule, Inc. Common Stock, also called ArQule, is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. Read More The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751 and Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.

Employees
36
Headquarters
Burlington, Massachusetts
Founded
1993
Market Cap
958.47M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.43M
High Today
$8.26
Low Today
$7.90
Open Price
$7.95
Volume
1.28M
52 Week High
$12.22
52 Week Low
$2.23

Collections

ARQL Earnings

-$0.09
-$0.04
$0.00
$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.